Tuesday, 6 December 2016

Adjuvant Phytotherapy against Antitubercular Drug Induced Hepatotoxicity



Tuberculosis was declared as a global pandemic and panic because the causative Mycobacterium tuberculosis can kill an incredible number of individuals which formulate a major obstacle to social and economic development of the country. Most of the developing countries are affected bytuberculosis. Antitubercular therapy involves the use of Directly ObservedTherapy Short (DOTS) course for 6-9 months. Antitubercular drug induced hepatic damage may occur with DOTS combination regimen which consists of an initial 2-month phase of 1st line combination therapy with pyrazinamide (PZA), isoniazid (INH), rifampin (RIF) and ethambutol (E) followed by a continuation phase of treatment lasting 4 months with INH and RIF. 

Drug Induced Hepatotoxicity

Metabolic idiosyncratic reactions appear to be responsible for most drugs induced liver injury from the first-line antitubercular medications and fluoroquinolones. Knowledge of the mechanisms of antitubercular drug-induced liver injury or hepatotoxicity is incomplete. Herbal drugs have gained importance and popularity in recent yearsbecause of their safety, efficacy and cost effectiveness. The association of medical plants with other plants in their habitat also influences their medicinal values in some cases. One of the important and well-documented uses of ethno medicinal plant products is their use as hepatoprotective agents which become ever increasing need for the treatment of antitubercular compounds induced hepatic cell damage.

No comments:

Post a Comment